Donor-Recipient ABO Compatibility Independently Influences Survival After Allogeneic HSCT: Outcomes of 281 Patients From a Single Centre
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.11.842
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2016
Authors
Publisher
Elsevier BV